Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

RDY

+ Watchlist+ Portfolio

Dr. Reddy's Laboratories Ltd

Regulated industryPhysical productsTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$14.79
52-Week Range
$11.36 – $15.67
Market Cap
$12.49B
P/E (TTM)
40.49
EPS (TTM)
0.37
Dividend Yield
0.56%
Advanced Metrics
Price/Book
18.25
PEG Ratio
2.03
Return on Equity
7.34%
Return on Assets
3.37%
Gross Margin
49.49%
Operating Margin
9.12%
Profit Margin
8.48%
Current Ratio
1.93
Debt/Equity
0.19
Total Debt
$72.29B
Free Cash Flow
$-6.59B
Revenue Growth
-1.50%
Earnings Growth
-35.70%
Enterprise Value
$73.96B

Market Snapshot

About

Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company focused on generic drugs, active pharmaceutical ingredients, and biosimilars. The company develops and manufactures affordable medicines across therapeutic areas including gastroenterology, cardiovascular, oncology, and pain management for global markets.